Page last updated: 2024-08-25

mannuronic acid and Breast Neoplasms

mannuronic acid has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmadi, H; Jafarnezhad-Ansariha, F; Kashefi, S; Mahmoodzadeh, H; Mirshafiey, A; Omranipour, R; Tofighi Zavareh, F	1
Ahmadi, H; Alikhassi, A; Cuzzocrea, S; Hosseini, M; Kashefi, S; Mahmoodzadeh, H; Matsuo, H; Mirshafiey, A; Omranipour, R; Rehm, BHA	1
Anissian, A; Enderami, SE; Fattahi, M; Hassannia, H; Hosseini, F; Jadidi-Niaragh, F; Kokhaei, P; Mahdian-Shakib, A; Mirshafiey, A	1

Trials

2 trial(s) available for mannuronic acid and Breast Neoplasms

Article	Year
The Anti-tumoral Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGFβ1 Gene Expression in Pre-surgical Breast Cancer Patients. Iranian journal of allergy, asthma, and immunology, 2019, Volume: 18, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemokine CCL22; Female; Gene Expression Regulation, Neoplastic; Hexuronic Acids; Humans; Lymphocyte Count; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1	2019
A randomized, controlled, phase II clinical trial of β-D-mannuronic acid (M2000) in pre-surgical breast cancer patients at early stage (T1-T2). Clinical and experimental pharmacology & physiology, 2019, Volume: 46, Issue:6 Topics: Breast Neoplasms; Female; Hexuronic Acids; Humans; Middle Aged; Neoplasm Staging; Safety	2019

Article

Year

The Anti-tumoral Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGFβ1 Gene Expression in Pre-surgical Breast Cancer Patients.

Iranian journal of allergy, asthma, and immunology, 2019, Volume: 18, Issue:1

Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemokine CCL22; Female; Gene Expression Regulation, Neoplastic; Hexuronic Acids; Humans; Lymphocyte Count; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1

2019

A randomized, controlled, phase II clinical trial of β-D-mannuronic acid (M2000) in pre-surgical breast cancer patients at early stage (T1-T2).

Clinical and experimental pharmacology & physiology, 2019, Volume: 46, Issue:6

Topics: Breast Neoplasms; Female; Hexuronic Acids; Humans; Middle Aged; Neoplasm Staging; Safety

2019

Other Studies

1 other study(ies) available for mannuronic acid and Breast Neoplasms

Article	Year
Targeting of crosstalk between tumor and tumor microenvironment by β-D mannuronic acid (M2000) in murine breast cancer model. Cancer medicine, 2017, Volume: 6, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Hexuronic Acids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Neoplasm Metastasis; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays	2017

Article

Year

Targeting of crosstalk between tumor and tumor microenvironment by β-D mannuronic acid (M2000) in murine breast cancer model.

Cancer medicine, 2017, Volume: 6, Issue:3

Topics: Animals; Anti-Inflammatory Agents; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Hexuronic Acids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Neoplasm Metastasis; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays

2017